In fact, besides the gradual accumulation of genomic lesions, the CLL clone is also dependent on active BcR signaling and interactions with the tumor microenvironment (TME) to promote clonal expansion. This evidence concerns the gene BCR and B-cell chronic lymphocytic leukemia.